jump to content jump to footer

University of Miami & Nova Souteastern University: Study shows feasibility of radiomics and T2 mapping as novel imaging biomarkers of activity in superficial fibromatosis

A retrospective study [1] conducted by researchers at University of Miami Miller School of Medicine and Nova Southeastern University investigated whether quantifying the heterogeneity of the MR signal intensity using image texture analysis and T2-mapping could provide more objective imaging biomarkers for response monitoring in superficial fibromatosis.

Superficial fibromatosis presents a particular challenge in objectively assessing the efficacy of treatment because changes in nodule composition can occur independently of changes in size. Moreover, nodules in this disease are often small and, consequently, absolute changes of only a few millimeters result in large percentage differences, making meaningful longitudinal comparisons difficult.

“Decreased T2 signal in the nodule during the course of therapy likely reflects a transition from the proliferative to a more quiescent phase marked by increased collagen deposition, and may be a better indicator of treatment response than decrease in size,“ explained the authors. “[…] to our knowledge, this is the first study to show that T2 mapping and radiomics analysis can detect longitudinal differences corresponding to biologic maturation in superficial fibromatosis.”

Baseline and follow-up MRI from 13 patients were evaluated. mint Lesion™ was used to draw and analyze regions of interest (ROI) in the regionally largest or most conspicuous nodule on proton-density MRI and corresponding T2-maps, when available. ROIs were also drawn in nearby muscle tissue and served as an internal reference for normalization and comparability of nodal signal intensity.

Comparisons were made between baseline and follow-up T2 relaxation times and radiomics features: entropy, kurtosis, skewness, mean of positive pixels (MPP), and uniformity of distribution of positive gray-level pixel values (UPP), which were calculated from the ROIs using the mint Lesion™ specific settings, implemented in accordance with the “Image Biomarker Standardization Initiative”.

Normalized T2 signal intensity and T2 relaxation time showed significant decrease (23%, p = 0.03, and 16%, p < 0.001), while skewness increased (73%, p = 0.03) and entropy decreased (4%, p = 0.05).

“Our findings support use of these measurements as novel imaging biomarkers of activity in superficial fibromatosis, and hint at the possibility of broader relevance in other fibroproliferative diseases,” concluded the researchers.

 

[1] Ramachandran A., Fox T., Wolfson A., Banks J., Subhawong T.K. (2021) Superficial fibromatosis: MRI radiomics and T2 mapping correlate with treatment response. Magnetic Resonance Imaging. doi.org/10.1016/j.mri.2021.06.003

Prof. Dr. Timm Denecke discusses AI-based early detection of liver cancer at RÖKO 2026
AI and MRI data may soon predict liver cancer risk before tumors form. Prof. Denecke explains the RACOON-MARDER project.
Predicting hepatocellular carcinoma (HCC) before it develops: Artificial Intelligence meets MRI
At RÖKO 2026, we spoke with Prof. Dr. Timm Denecke, Director of Radiology at Leipzig University Hospital, about RACOON-MARDER, a research project…
Read more
Portrait of Professor Christina Messiou, Consultant Radiologist at The Royal Marsden NHS Foundation Trust
Professor Christina Messiou, Consultant Radiologist at The Royal Marsden NHS Foundation Trust and Professor at the Institute of Cancer Research, discusses AI-powered whole-body MRI for multiple myeloma
AI-Powered Whole-Body MRI for Multiple Myeloma: Interview with Prof. Christina Messiou
Multiple myeloma poses a unique challenge for radiologists: the disease often affects the bone marrow unevenly, and conventional biopsies can only…
Read more
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026
Presentation of a research poster by Memorial Sloan Kettering Cancer Center on the use of mint Lesion for structured tumor response assessments and clinical research workflows.
NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion
Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of…
Read more
scroll-top